GMP Tips - Former FDA Chief Charged with Lying - Oct 17, 2006

Former FDA Commissioner Lester Crawford was charged Monday with lying about his ownership of stock in companies regulated by his agency. According to the Wall Street Journal, Crawford plans to plead guilty to two misdemeanors in connection with not disclosing investments in companies that his agency regulated.

The Justice Department accused Crawford with falsely reporting that he had sold stock in companies when he continued holding onto shares in the firms governed by FDA rules. Crawford also failed to disclose his income from exercising stock options in Embrex, an agriculture biotechnology company regulated by FDA.

AND WE'RE STILL WAITING for the Senate to vote to confirm the current Acting Commissioner, Andrew von Eschenbach. He's been Acting Commissioner since September 2005, when Crawford resigned after just two months as Commissioner. Now we know why he resigned.

GMP Training Systems, Inc.
www.GMPTrainingSystems.com
Serving 933 clients since 1996

Please forward this post to others in your organization who might benefit.